Watch as Johnson & Johnson’s Dr. Mathai Mammen, Global Head of R&D discusses how the company’s new global COVID-19 vaccine clinical trial will work, how safety is a top priority and why the company has chosen to vaccinate up to 60,000 people in Phase 3.
Be sure to tune in for the next live episode of Johnson & Johnson’s weekly live web series, “The Road to a Vaccine," which airs on Tuesdays at 12:00 PM ET.
Subscribe to J&J on YouTube and keep up-to-date with the latest episodes: : [ Ссылка ]
Connect with Johnson & Johnson on social media:
J&J on Facebook: [ Ссылка ]
JNJ News on Twitter: [ Ссылка ]
J&J on LinkedIn: [ Ссылка ]
Find updates and news about J&J, including the company’s ongoing work on a potential COVID-19 vaccine, here:
J&J’s Latest News: [ Ссылка ]
